Search Results - "Lecumberri, Maria José"

Study of cutaneous melanoma recurrences after sentinel node biopsy: Patterns of dissemination and use of complementary test in follow‐up by Loidi‐Pascual, Leire, Lecumberri‐Biurrun, Maria José, Arozarena‐Martinicorena, Imanol, Goñi‐Gironés, Elena, Yanguas‐Bayona, Juan Ignacio

“…Objectives To investigate the patterns of melanoma recurrence in the local population, including factors that may influence in this event and timing of…”
Get full text

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer by Bocanegra, Ana, Fernandez-Hinojal, Gonzalo, Zuazo-Ibarra, Miren, Arasanz, Hugo, Garcia-Granda, Maria Jesus, Hernandez, Carlos, Ibañez, Maria, Hernandez-Marin, Berta, Martinez-Aguillo, Maite, Lecumberri, Maria Jose, Fernandez de Lascoiti, Angela, Teijeira, Lucia, Morilla, Idoia, Vera, Ruth, Escors, David, Kochan, Grazyna

“…PD-L1 tumor expression is a widely used biomarker for patient stratification in PD-L1/PD-1 blockade anticancer therapies, particularly for lung cancer…”
Get full text

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study by Escobar, Yolanda, Cajaraville, Gerardo, Virizuela, Juan Antonio, Álvarez, Rosa, Muñoz, Andrés, Olariaga, Olatz, Tamés, María José, Muros, Begoña, Lecumberri, María Jose, Feliu, Jaime, Martínez, Purificación, Adansa, Juan Carlos, Martínez, María José, López, Rafael, Blasco, Ana, Gascón, Pere, Calvo, Virginia, Luna, Pablo, Montalar, Joaquín, Del Barrio, Patricia, Tornamira, María Victoria

“…Purpose This study aims to determine the incidence of nausea and vomiting (CINV) after moderately emetogenic chemotherapy (MEC), under medical practice…”
Get full text

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO) by Rubio, María Jesús, Lecumberri, María José, Varela, Silvia, Alarcón, Jesús, Ortega, María Eugenia, Gaba, Lydia, Espinós, Jaime, Calzas, Julia, Barretina, Pilar, Ruiz, Isabel, Marquina, Gloria, Santaballa, Ana

“…•Trabectedin confers clinical benefit in patients with recurrent/metastatic uterine leiomyosarcoma.•Our data are similar to those previously reported in…”
Get full text

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy by Zuazo, Miren, Arasanz, Hugo, Fernández-Hinojal, Gonzalo, García-Granda, Maria Jesus, Gato, María, Bocanegra, Ana, Martínez, Maite, Hernández, Berta, Teijeira, Lucía, Morilla, Idoia, Lecumberri, Maria Jose, Fernández de Lascoiti, Angela, Vera, Ruth, Kochan, Grazyna, Escors, David

“…The majority of lung cancer patients progressing from conventional therapies are refractory to PD-L1/PD-1 blockade monotherapy. Here, we show that baseline…”
Get full text

Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy by Zuazo, Miren, Arasanz, Hugo, Fernández‐Hinojal, Gonzalo, García‐Granda, Maria Jesus, Gato, María, Bocanegra, Ana, Martínez, Maite, Hernández, Berta, Teijeira, Lucía, Morilla, Idoia, Lecumberri, Maria Jose, Fernández de Lascoiti, Angela, Vera, Ruth, Kochan, Grazyna, Escors, David

“…The majority of lung cancer patients progressing from conventional therapies are refractory to PD‐L1/PD‐1 blockade monotherapy. Here, we show that baseline…”
Get full text

Immunotherapy in malignant melanoma: recent approaches and new perspectives by Arasanz, Hugo, Lacalle, Alejandra, Lecumberri, Maria José, de Lascoiti, Ángela Fernández, Blanco-Luquin, Idoia, GatoCañas, María, Pérez-Ricarte, Leyre, Zuazo, Miren, Kochan, Grazyna, Escors, David

“…Immunotherapy has radically transformed the management of metastatic malignant melanoma. Ipilimumab, a CTLA-4-targeted monoclonal antibody, was the first…”
Get full text

Determinants of patient satisfaction with care in a Spanish oncology Day Hospital and its relationship with quality of life by Arraras, Juan Ignacio, Illarramendi, Jose Juan, Viudez, Antonio, Ibáñez, Berta, Lecumberri, Maria Jose, de la Cruz, Susana, Hernandez, Berta, Zarandona, Uxue, Cambra, Koldo, Martinez, Maite, Salgado, Esteban, Lainez, Nuria, Vera, Ruth

“…Objective This study evaluates satisfaction with care (SC) in cancer patients treated at a Spanish day hospital to identify SC determinants and assess the…”
Get full text

The cancer outpatient satisfaction with care questionnaire for chemotherapy, OUT-PATSAT35 CT: a validation study for Spanish patients by Arraras, Juan Ignacio, Illarramendi, Jose Juan, Viudez, Antonio, Lecumberri, Maria Jose, de la Cruz, Susana, Hernandez, Berta, Zarandona, Uxue, Bredart, Anne, Martinez, Maite, Salgado, Esteban, Lainez, Nuria, Vera, Ruth

“…Purpose The OUT-PATSAT35 CT questionnaire evaluates satisfaction with care expressed by cancer outpatients receiving chemotherapy. This study assesses the…”
Get full text

Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801 by Berciano-Guerrero, Miguel-Ángel, Perez-Ruiz, Elisabeth, Muñoz Couselo, Eva, Manzano, Jose Luis, Cerezuela-Fuentes, Pablo, Ayala de Miguel, Pablo, Soria, Ainara, García Castaño, Almudena, Crespo, Guillermo, Puértolas, Teresa, Aguado De La Rosa, Carlos, Gutiérrez Sanz, Lourdes, López Castro, Rafael, Espinosa, Enrique, Lecumberri, Maria José, Majem, Margarita, Medina Martinez, Javier, Bellido, Lorena, Fernández-Morales, Luis Antonio, Martin-Algarra, Salvador

“…e21515 Background: Dabrafenib-Trametinib (DT) is included in the therapeutic arsenal for BRAFV600-mutant metastatic melanoma. However, detailed effectiveness…”
Get full text

Erratum to: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study by Escobar, Yolanda, Cajaraville, Gerardo, Virizuela, Juan Antonio, Álvarez, Rosa, Muñoz, Andrés, Olariaga, Olatz, Tamés, María José, Muros, Begoña, Lecumberri, María Jose, Feliu, Jaime, Martínez, Purificación, Adansa, Juan Carlos, Martínez, María José, López, Rafael, Blasco, Ana, Gascón, Pere, Calvo, Virginia, Luna, Pablo, Montalar, Joaquín, Del Barrio, Patricia, Tornamira, María Victoria

Get full text

Skull metastasis from rectal gastrointestinal stromal tumours by Gil-Arnaiz, Irene, Martínez-Trufero, Javier, Pazo-Cid, Roberto Antonio, Felipo, Francesc, Lecumberri, María José, Calderero, Verónica

“…Gastrointestinal stromal tumours (GIST) are the most common mesenchymal neoplasm of the gastrointestinal tract. Rectum localisation is infrequent for these…”
Get full text

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study by Martín Algarra, Salvador, Soriano, Virtudes, Fernández-Morales, Luis, Berciano-Guerrero, Miguel-Ángel, Mujika, Karmele, Manzano, José Luis, Puértolas Hernández, Teresa, Soria, Ainara, Rodríguez-Abreu, Delvys, Espinosa Arranz, Enrique, Medina Martínez, Javier, Márquez-Rodas, Ivan, Rubió-Casadevall, Jordi, Ortega, María Eugenia, Jurado García, José Miguel, Lecumberri Biurrun, María José, Palacio, Isabel, Rodríguez de la Borbolla Artacho, María, Altozano, Javier Pérez, Castellón Rubio, Victoria Eugenia, García, Almudena, Luna, Pablo, Ballesteros, Anabel, Fernández, Ovidio, López Martín, Jose Antonio, Berrocal, Alfonso, Arance, Ana

“…The main objective of the study was to evaluate the efficacy and safety of dabrafenib alone or combined with trametinib for compassionate use in patients with…”
Get full text

A multicenter phase 2 study of nivolumab combined with ipilimumab in patients with pediatric solid tumors in adulthood (GETHI021) by Mielgo, Xabier, Diaz Beveridge, Robert, Pineda, Estela, Sepúlveda, Juan Manuel, López Castro, Rafael, Lecumberri-Biurrun, Maria José, Vaz Salgado, María Ángeles, De Las Penas, Ramon, López-López, Carlos, Rodriguez Salas, Nuria, virizuela, Juan Antonio, Lopez, Rafael, Medina, Javier, Valverde, Claudia, Beato, Carmen, Lainez, Nuria, Rodríguez-Antona, Cristina, Berraondo, Pedro, Herrador, Alejandro, GarcÃa-Donas, Jesús

“…Abstract only…”
Get full text

Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: Results from the observational study GEM1801 by Ayala de Miguel, Pablo, Berciano-Guerrero, Miguel-Angel, Muñoz-Couselo, Eva, Manzano, Jose Luis, CEREZUELA Fuentes, Pablo, SORIA RIVAS, AINARA, García Castaño, Almudena, Crespo, Guillermo, Puértolas, Teresa, Aguado De La Rosa, Carlos, Gutiérrez Sanz, Lourdes, López Castro, Rafael, Espinosa, Enrique, Lecumberri, Maria Jose, Majem, Margarita, Medina Martinez, Javier, Bellido, Lorena, Fernandez, Luis Antonio, Martin-Algarra, Salvador, Marquez-Rodas, Ivan

“…9547 Background: Most patients with BRAF-mutant melanoma eventually develop resistance to therapy with BRAF/MEK inhibitors and immune-checkpoint blockade…”
Get full text

Interim analysis of a phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumors in adulthood (GETHI021) by Mielgo, Xabier, Diaz-Beveridge, Robert, Sepulveda, Juan Manuel, Pineda, Estela, Lecumberri, Maria Jose, De Las Penas, Ramon, Rodriguez Salas, Nuria, Valverde, Claudia, López Castro, Rafael, Vaz, Maria Angeles, Lopez Lopez, Carlos, Virizuela, Juan Antonio, Medina, Javier, Lopez, Rafael, Rodríguez-Antona, Cristina, Berraondo, Pedro, Rodriguez-Moreno, Juan Francisco, Moreno, Diana, Martin Hernandez, Raquel, Garcia-Donas, Jesus

“…Abstract only 2613 Background: Solid pediatric tumors that appear in adulthood are a heterogeneous group characterized by a low incidence, lack of standard…”
Get full text

Functional systemic CD 4 immunity is required for clinical responses to PD ‐L1/ PD ‐1 blockade therapy by Zuazo, Miren, Arasanz, Hugo, Fernández‐Hinojal, Gonzalo, García‐Granda, Maria Jesus, Gato, María, Bocanegra, Ana, Martínez, Maite, Hernández, Berta, Teijeira, Lucía, Morilla, Idoia, Lecumberri, Maria Jose, Fernández de Lascoiti, Angela, Vera, Ruth, Kochan, Grazyna, Escors, David

“…The majority of lung cancer patients progressing from conventional therapies are refractory to PD‐L1/PD‐1 blockade monotherapy. Here, we show that baseline…”
Get full text

Abstract 5416: RNA-seq and proteomics to identify response to immunotherapy in advanced melanoma: a Spanish Melanoma Group Study by Trilla-Fuertes, Lucia, Prado-Vazquez, Guillermo, Gámez-Pozo, Angelo, Lopez-Vacas, Rocio, Herrera, Maria Isabel Lumbreras, Soriano, Virtudes, Garicano, Fernando, Lecumberri, Maria Jose, Rodriguez, Maria, Majem, Margarita, Perez, Elisabeth, Gonzalez-Cao, Maria, Oramas, Juana, Magdaleno, Alejandra, Fra, Joaquin, Martin, Alfonso, Corral, Monica, Puertolas, Teresa, Vara, Juan Angel Fresno, Espinosa, Enrique

“…Background: Prediction of response to immunotherapy remains an unmet need in the field of advanced melanoma. Methods: Computational analyses, including…”
Get full text

Crizotinib in advanced ALK-positive non-small cell lung cancer: Results of a retrospective cohort in Complejo Hospitalario de Navarra, Spain by Hernandez, Berta, Martinez, Maite, Teijeira, Lucia, Guerrero, David, Mata, Elena, Gil, Irene, Castillo, Ainhoa, Verdun, Juan, Rivadeneira, Jose Antonio, Ochoa, Patricia, Aznarez, Esther, Morilla, Idoia, De La Cruz, Susana, Hernandez, Irene, Lecumberri, Maria Jose, Viudez, Antonio, Vera, Ruth

“…Abstract only…”
Get full text

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO) by Rubio, María Jesús, Lecumberri, María José, Varela, Silvia, Alarcón, Jesús, Ortega, María Eugenia, Gaba, Lydia, Espinós, Jaime, Calzas, Julia, Barretina, Pilar, Ruiz, Isabel, Marquina, Gloria, Santaballa, Ana

“…OBJECTIVEWe assessed trabectedin in patients with advanced uterine leiomyosarcoma (uLMS) in real-life clinical practice given according to the marketing…”
Get full text